4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000950170-23-044379
Director acquired 9,604 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Walker Neal Director | 2023-08-22 | Option exercise | +9,604 | $0.55 | $5,301 | 15,854 | D |
| Derivatives | |||||||
| Walker Neal Director | 2023-08-22 | Option exercise · Stock Option (Right to Buy) | −9,604 | 0 | D | ||
Loading xslF345X05/ownership.xml…